ARTICLE | Finance
BioCentury’s Venture Report also includes fundings for Nuclera, TenNor, Shift, Tolerance and Sunbird
By Paul Bonanos, Director of Biopharma Intelligence
October 18, 2024 12:45 AM UTC
Early-stage investor KdT Ventures will have more than $100 million in fresh capital to back start-ups across a range of life sciences sectors, including biopharmas.
The Austin and North Carolina-based firm closed its fourth fund just over two years after announcing its $80 million third fund. KdT has invested in 65 companies thus far; about two dozen of its deals have been in the biopharma space, according to BioCentury’s BCIQ database, while others are in the agricultural or chemical sectors…
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.biocentury.com/article/653901/kdt-closes-new-100m-fund-portfolio-company-terray-draws-120m-series-b